Gap funding may be awarded to support delayed NIH-sponsored programs that have undergone peer review and have received fundable priority scores (based on clearly exceeding the historic institute paylines [usually by half] or by written confirmation from NIH). Internal Gap funding will be time-limited (up to 6 months) in order to compensate for delays in federal approval and the release of funds.
This program is not intended to address shifting NIH funding priorities nor the potential impact of changes in institutional ICR.
Priority will be given to large Center, Multi-PI, and Program Project grants, Training grants, as well as to early career investigator awards, including T32 awards, F awards, K awards, and ESI RO1 awards. Competitive renewals of RO1 type awards where funding gaps might result in jeopardized staff or trainee support or loss of a valuable reagent (such as a bioengineered mouse colony) will also be prioritized. For training grants, personnel to whom support has been committed will be prioritized, but potential (unfilled) positions will not be funded. Non-competitive renewal of grants are not eligible for these funds. Additionally, funds will only support expenses and/or personnel that are within the CU School of Medicine.
Funding to sustain federally supported clinical trials will be considered with priority given to supporting jeopardized personnel and maintaining patient enrollment, provided that an argument can be made that a brief pause in recruitment would jeopardize the overall project viability.
New R01 grants from established investigators whose funding is delayed will not be prioritized.
Support will be prorated and will likely be in the order of 50% of the total direct costs of the grant and focused on salary support (especially for trainees) and other elements that if not supported would significantly jeopardize program viability.
The expectation is that awardees will commit their personal reserves and start-up funds before requesting Gap funding.
Process for applying for support